Is there a case for hepatitis C infection screening in the antenatal period?

Area of Science:

• Hepatology
• Public Health Screening
• Infectious Disease Epidemiology

Background:

• Hepatitis C virus (HCV) infection poses a significant public health challenge.
• Antenatal screening programs are crucial for early detection and management of infections in pregnant individuals.
• The UK National Screening Committee evaluates evidence for new screening initiatives.

Purpose of the Study:

• To review the evidence base informing the UK National Screening Committee's decision on antenatal HCV screening.
• To outline the essential criteria for evaluating the introduction of new national screening programs.

Main Methods:

• Evidence synthesis of research studies on HCV prevalence and impact in pregnancy.
• Analysis of screening program implementation criteria.
• Review of UK National Screening Committee recommendations and guidelines.

Main Results:

• The UK National Screening Committee concluded against introducing routine antenatal HCV screening.
• Key criteria for screening program adoption were critically assessed.

Conclusions:

• The decision not to implement routine antenatal HCV screening was based on comprehensive evidence review.
• A robust framework of criteria is essential for evaluating any proposed new national screening program.